Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Trial Type:  Treatment
Treatment/Intervention:  RNA interference therapy
Results 1-1 of 1 for your search:
Start Over
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Status: Enrolling by invitation
Phase: Phase III
Type: Treatment
Age: 18 to 85
Trial IDs: ALN-TTR02-006, NCI-2017-00574, NCT02510261
Start Over